Penumbra, Inc. (PEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 204.04 |
| Open | 204.46 |
| Bid | 190.77 x 900 |
| Ask | 240.00 x 800 |
| Day's range | 199.93 - 206.00 |
| 52-week range | 148.00 - 302.00 |
| Volume | |
| Avg. volume | 457,859 |
| Market cap | 7.914B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 582.09 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
The transaction was documented in an SEC Filing. Following this sale, the insider now owns 61,088 shares of Penumbra Inc. Penumbra Inc, a healthcare company, is primarily engaged in the design, development, manufacture, and marketing of innovative medical devices.
- GuruFocus.com
Insider Sale: Director Harpreet Grewal Sells Shares of Penumbra Inc (PEN)
Following this transaction, the insider now owns 8,863 shares of Penumbra Inc. Penumbra Inc, based in Alameda, California, is a healthcare company focused on developing innovative medical devices. Over the past year, Harpreet Grewal has sold a total of 1,122 shares of Penumbra Inc and has not made any purchases of the stock.
- Zacks
Why Is Penumbra (PEN) Up 20% Since Last Earnings Report?
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.